Evidence map›Paper›PMID 38046038›Full record

ArticleClinical kidney journal2023

Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation.

Cédric Villain, Natalie Ebert, Tim Bothe, Muhammad Barghouth, Anna Pöhlmann, Anne-Katrin Fietz, Antonios Douros, Nina Mielke, Elke Schaeffner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cédric VillainCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-2050-2767
Natalie EbertCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-4463-3315
Tim BotheCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0003-4404-2379
Muhammad BarghouthCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-5721-9367
Anna PöhlmannCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-1494-3240
Anne-Katrin FietzCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-4395-4176
Antonios DourosDepartments of Medicine and of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-6005-4006
Nina MielkeCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-8951-9823
Elke SchaeffnerCharité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Public Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-7925-4577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Cockcroft-Gault equation (CrCl Methods: Participants of the Berlin Initiative Study with AF and treated with DOACs were included. We investigated CrCl Results: A total of 224 patients were included in the analysis (median age 87 years). Using CrCl Conclusion: In older adults with AF, the association of DOAC dose status with adverse events did not differ when using CrCl

Indexed as

atrial fibrillationcreatinine clearanceglomerular filtration rateolder adultsoral anticoagulant drug

Identifiers

PMID38046038
PMCPMC10689126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.